TDOC - Teladoc Health, Inc.
NYSE
->
Healthcare
->
Health Information Services
Purchase,
United States
Type: Equity
TDOC price evolution
TDOC
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1123.67 | $1030.53 | $958.7 | $888.58 |
| Short term investments | ||||
| Net receivables | $217.42 | $205.87 | $215.18 | $215.98 |
| Inventory | $29.51 | $35.92 | $34.05 | $45.8 |
| Total current assets | $1489.05 | $1387.09 | $1320.96 | $1286.71 |
| Long term investments | ||||
| Property, plant & equipment | $72.09 | $64.94 | $65.22 | $69.31 |
| Goodwill & intangible assets | $2750.97 | $2801.49 | $2857.3 | $2889.14 |
| Total noncurrent assets | $2903.32 | $2940.88 | $2995.44 | $3022.44 |
| Total investments | ||||
| Total assets | $4392.37 | $4327.97 | $4316.4 | $4309.15 |
| Current liabilities | ||||
| Accounts payable | $43.64 | $26 | $16.07 | $38.63 |
| Deferred revenue | $109.28 | $112.34 | $121.63 | $100.05 |
| Short long term debt | $11.25 | |||
| Total current liabilities | $420.62 | $402.64 | $383.39 | $381.34 |
| Long term debt | $1581.53 | $1572.19 | $1573.79 | $1580.1 |
| Total noncurrent liabilities | $1645.68 | $1631.28 | $1637.87 | $1636.58 |
| Total debt | $1581.53 | $1572.19 | $1573.79 | $1591.35 |
| Total liabilities | $2066.3 | $2033.92 | $2021.26 | $2017.92 |
| Shareholders' equity | ||||
| Retained earnings | -$15228.66 | -$15199.76 | -$15142.69 | -$15077.51 |
| Other shareholder equity | -$36.99 | -$41.52 | -$38.78 | -$41 |
| Total shareholder equity | $2326.07 | $2294.05 | $2295.14 | $2291.23 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1123.67 | $918.18 | $893.48 | $733.32 |
| Short term investments | $2.54 | $53.24 | ||
| Net receivables | $217.42 | $235.65 | $168.96 | $169.28 |
| Inventory | $29.51 | $56.34 | $73.08 | $56.5 |
| Total current assets | $1489.05 | $1315.39 | $1225.44 | $1059.61 |
| Long term investments | ||||
| Property, plant & equipment | $72.09 | $71.47 | $74.01 | $75.2 |
| Goodwill & intangible assets | $2750.97 | $2909.95 | $16414.45 | $16602.12 |
| Total noncurrent assets | $2903.32 | $3029.97 | $16509.17 | $16695.67 |
| Total investments | $2.54 | $53.24 | ||
| Total assets | $4392.37 | $4345.35 | $17734.61 | $17755.28 |
| Current liabilities | ||||
| Accounts payable | $43.64 | $47.69 | $47.26 | $46.03 |
| Deferred revenue | $109.28 | $94.33 | $79.4 | $54.8 |
| Short long term debt | $11.38 | $13.31 | $56.01 | |
| Total current liabilities | $420.62 | $399.77 | $331.01 | $332.65 |
| Long term debt | $1581.53 | $1543.37 | $1276.73 | $1432.66 |
| Total noncurrent liabilities | $1645.68 | $1637.84 | $1357.84 | $1538.83 |
| Total debt | $1581.53 | $1592.79 | $1290.05 | $1488.67 |
| Total liabilities | $2066.3 | $2037.61 | $1688.85 | $1871.48 |
| Shareholders' equity | ||||
| Retained earnings | -$15228.66 | -$15008.29 | -$1421.45 | -$992.66 |
| Other shareholder equity | -$36.99 | -$42.78 | -$6.29 | $18.52 |
| Total shareholder equity | $2326.07 | $2307.74 | $16045.76 | $15883.8 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $660.53 | $660.24 | $629.24 | |
| Cost of revenue | $193.42 | $185.96 | $190.11 | |
| Gross Profit | $467.1 | $474.28 | $439.14 | |
| Operating activities | ||||
| Research & development | $89.94 | $84.29 | $86.98 | |
| Selling, general & administrative | $309.56 | $354.18 | $345.43 | |
| Total operating expenses | $502.18 | $539 | $516.24 | |
| Operating income | -$35.08 | -$64.72 | -$77.1 | |
| Income from continuing operations | ||||
| EBIT | -$19.84 | -$53.91 | -$72.19 | |
| Income tax expense | $3.52 | -$2.48 | $0.68 | |
| Interest expense | $5.54 | $5.65 | -$3.65 | |
| Net income | ||||
| Net income | -$28.89 | -$57.07 | -$69.23 | |
| Income (for common shares) | -$28.89 | -$57.07 | -$69.23 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2602.41 | $2406.84 | $2032.71 | $1093.96 |
| Cost of revenue | $760.03 | $743.99 | $650.26 | $390.83 |
| Gross Profit | $1842.38 | $1662.85 | $1382.45 | $703.13 |
| Operating activities | ||||
| Research & development | $348.52 | $333.63 | $311.88 | $164.94 |
| Selling, general & administrative | $1367.29 | $1300.56 | $1105.31 | $886.88 |
| Total operating expenses | $2090.94 | $15316.07 | $1648.08 | $1209.55 |
| Operating income | -$248.55 | -$13653.21 | -$265.63 | -$506.42 |
| Income from continuing operations | ||||
| EBIT | -$197.33 | -$13654.07 | -$304.29 | -$515.5 |
| Income tax expense | $0.76 | -$3.81 | $44.14 | -$90.86 |
| Interest expense | $22.28 | $9.27 | $80.36 | $60.49 |
| Net income | ||||
| Net income | -$220.37 | -$13659.53 | -$428.79 | -$485.14 |
| Income (for common shares) | -$220.37 | -$13659.53 | -$428.79 | -$485.14 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$28.89 | -$57.07 | -$65.18 | -$69.23 |
| Operating activities | ||||
| Depreciation | $101.48 | $97.49 | $78.83 | $73.52 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $46.82 | $52.96 | $55.73 | $46.04 |
| Total cash flows from operations | $130.08 | $105.6 | $101.18 | $13.16 |
| Investing activities | ||||
| Capital expenditures | -$36.51 | -$37.65 | -$36.57 | -$45.62 |
| Investments | ||||
| Total cash flows from investing | -$36.51 | -$37.65 | -$36.57 | -$45.62 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.11 | $3.91 | $3.08 | $3.03 |
| Net borrowings | $3.55 | -$3.55 | ||
| Total cash flows from financing | -$1.77 | $5.07 | $4.21 | $3.35 |
| Effect of exchange rate | $1.35 | -$1.19 | $1.3 | -$0.49 |
| Change in cash and equivalents | $91.8 | $73.02 | $68.82 | -$29.11 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$220.37 | -$13659.53 | -$428.79 | -$485.14 |
| Operating activities | ||||
| Depreciation | $351.32 | $270.64 | $219.62 | $78.09 |
| Business acquisitions & disposals | -$78.66 | -$567.43 | ||
| Stock-based compensation | $201.55 | $217.85 | $302.59 | $475.53 |
| Total cash flows from operations | $350.02 | $189.29 | $193.99 | -$53.51 |
| Investing activities | ||||
| Capital expenditures | -$156.35 | -$172.76 | -$63.93 | -$26.04 |
| Investments | $2.51 | $60.9 | $2.5 | |
| Total cash flows from investing | -$156.35 | -$167.74 | -$72.98 | -$590.98 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $11.13 | $12.38 | $42.59 | $59.04 |
| Net borrowings | -$15.02 | -$16.19 | $737.78 | |
| Total cash flows from financing | $10.85 | $6.5 | $40.95 | $859.14 |
| Effect of exchange rate | $0.96 | -$3.34 | -$1.8 | $4.32 |
| Change in cash and equivalents | $204.53 | $28.05 | $161.96 | $214.65 |
News
Fundamentals
| Market cap | $2.29B |
|---|---|
| Enterprise value | $2.75B |
| Shares outstanding | 166.66M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 3.58% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.97 |
| Book/Share | 14.18 |
| Cash/Share | 6.74 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.89 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.54 |
| Quick ratio | 3.47 |